| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/2009 | WO2009047336A1 Phthalazine and pyrido [3,4-d] pyridaz ine compounds as h1 receptor antagonists |
| 04/16/2009 | WO2009047323A2 Isoxazole compound for the treatment of cancer |
| 04/16/2009 | WO2009047312A1 Solid pharmaceutical composition comprising tamsulosin |
| 04/16/2009 | WO2009047303A2 Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder |
| 04/16/2009 | WO2009047298A2 Dimers of harmol or of its derivatives and uses thereof |
| 04/16/2009 | WO2009047296A2 Metabotropic glutamate receptor modulators for the treatment op parkinson's disease |
| 04/16/2009 | WO2009047291A2 Use of quaternary pyridinium salts for inhibiting cancer metastases |
| 04/16/2009 | WO2009047290A1 Use of quaternary pyridinium salts for radioprotection |
| 04/16/2009 | WO2009047264A1 Spiropyrrolidines and their use against hcv and hiv infection |
| 04/16/2009 | WO2009047255A1 Heterobicyclic compounds as histamine h4-receptor antagonists |
| 04/16/2009 | WO2009047240A1 Indole derivatives useful as ppar activators |
| 04/16/2009 | WO2009047216A2 Use of indolocarbazole imides as protein kinase inhibitors for the treatment of hematologic and solid tumors |
| 04/16/2009 | WO2009047163A1 Methods of treating inflammatory diseases |
| 04/16/2009 | WO2009047161A1 Chiral cis-imidazolines |
| 04/16/2009 | WO2009047101A1 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders |
| 04/16/2009 | WO2009047006A2 Amphoteric liposomes comprising neutral lipids |
| 04/16/2009 | WO2009046967A1 Aqueous ophthalmic formulations |
| 04/16/2009 | WO2009046842A2 Thiazol derivatives for treating cancer |
| 04/16/2009 | WO2009046841A2 Piperidine and piperazine derivatives for treating tumours |
| 04/16/2009 | WO2009046804A1 Imidazole derivatives |
| 04/16/2009 | WO2009046802A1 N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators |
| 04/16/2009 | WO2009046784A1 Pyridine derivatives useful as glucokinase activators |
| 04/16/2009 | WO2009046640A1 Myrothecium sp. mycelial extract for inhibiting tumor cells growth |
| 04/16/2009 | WO2009046635A1 Use of alkaloids in preparing medicaments for treating cough |
| 04/16/2009 | WO2009046620A1 Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof |
| 04/16/2009 | WO2009046606A1 Pyrimidinyl-propionic acid derivatives and their use as ppar agonists |
| 04/16/2009 | WO2009046580A1 The application of the combination of insulin or oral hypoglycemic medicine with raceanisodamine hydrochloride, vitamin b12 and nerve growth factor in the preparation of medicine for treating type ii diabetes |
| 04/16/2009 | WO2009046573A1 Liver targeting adefovir prodrug and its medical use |
| 04/16/2009 | WO2009046536A1 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 04/16/2009 | WO2009046530A1 Compositions affecting hyaluronic acid mediated activity |
| 04/16/2009 | WO2009027994A3 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
| 04/16/2009 | WO2009026389A3 Regulating glp-1 and sglt-1 in gastrointestinal cells |
| 04/16/2009 | WO2009023846A3 Methods for heat shock protein dependent cancer treatment |
| 04/16/2009 | WO2009023495A3 Bisubstrate inhibitors of adenylosuccinate synthetase |
| 04/16/2009 | WO2009022066A3 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/16/2009 | WO2009022065A3 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/16/2009 | WO2009022064A3 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/16/2009 | WO2009022063A3 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/16/2009 | WO2009021992A3 Fused bicyclic pyrimidines |
| 04/16/2009 | WO2009021965A3 Substituted quinoline derivatives as h1 receptor antagonists |
| 04/16/2009 | WO2009020234A3 Pyrrolidin-2 -one derivatives as androgen receptor modulator |
| 04/16/2009 | WO2009019371A3 Use of a material based on a thermoplastic polymer having a high content of antioxidants for packaging dianhydrohexitols |
| 04/16/2009 | WO2009019007A3 Sdf-1 binding nucleic acids and the use thereof |
| 04/16/2009 | WO2009016516A8 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 04/16/2009 | WO2009016379A3 Nr4a agonists ( 6-mercaptopurine) for inhibition of non-ocular scarring |
| 04/16/2009 | WO2009010810A3 Cardiovascular combinations comprising ace and hmg-co-a inhibitors |
| 04/16/2009 | WO2009010660A3 Substituted indazoles, the preparation thereof, and use of same in therapeutics |
| 04/16/2009 | WO2009007992A3 Pharmaceutical composition produced by microprecipitation |
| 04/16/2009 | WO2009006043A3 Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a]pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepine |
| 04/16/2009 | WO2009002652A3 Use of surfactants for treating mycobacterial infections |
| 04/16/2009 | WO2009002538A3 Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib |
| 04/16/2009 | WO2009000832A3 Chemical compounds |
| 04/16/2009 | WO2008157365A3 Vinylazacycloalkanes for treating neuropathic pain |
| 04/16/2009 | WO2008156513A9 Methods to protect skeletal muscle against injury |
| 04/16/2009 | WO2008153947A3 Heterocyclic compounds as raf kinase modulators |
| 04/16/2009 | WO2008148849A3 Piperidine/piperazine derivatives |
| 04/16/2009 | WO2008147480A4 Hydroxamic acid derivatives of 3-phenyl propionic acids useful as thrapeutic agents for treating anthrax poisoning |
| 04/16/2009 | WO2008139210A3 Process for obtaining steroidal phosphate compounds |
| 04/16/2009 | WO2008135795A3 Polymorphic forms of bosentan |
| 04/16/2009 | WO2008134668A3 Heat-labile prodrugs |
| 04/16/2009 | WO2008134646A3 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 04/16/2009 | WO2008130630A4 Polymorphic form of rimonabant hydrochloride and processes for preparation thereof |
| 04/16/2009 | WO2008124571A3 Anti-viral compounds, compositions and methods |
| 04/16/2009 | WO2008118278A9 Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints |
| 04/16/2009 | WO2008115707A3 Post-exposure prophylaxis and treatment of infections caused by anthrax |
| 04/16/2009 | WO2008113364A3 Amino derivatives to prevent nephrotoxicity and cancer |
| 04/16/2009 | WO2008109548A4 Nucleic acid compounds for inhibiting tgfb gene expression and uses thereof |
| 04/16/2009 | WO2008108380A3 Pyrrole compounds |
| 04/16/2009 | WO2008103277A3 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors |
| 04/16/2009 | WO2008096189A3 Piperidine and piperazine derivatives |
| 04/16/2009 | WO2008093148A3 Compositions and methods for prevention and treatment of cachexia |
| 04/16/2009 | WO2008083160A3 Methods and compositions for therapeutic treatment |
| 04/16/2009 | WO2008076156A3 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches |
| 04/16/2009 | WO2008075371A3 T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation |
| 04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 04/16/2009 | WO2008070072A3 Carvedilol forms, compositions, and methods of preparation thereof |
| 04/16/2009 | WO2008068746A3 Disulfiram doses and treatment regimen suitable for treatment of angiogenesis-dependent disorders |
| 04/16/2009 | WO2008067982A3 Use of carrageenan for treating rhinovirus infections |
| 04/16/2009 | WO2008067027A3 Compositions of chkl inhibitors and cyclodextrin |
| 04/16/2009 | WO2008066899A3 Nanoparticulate formulations and methods for the making and use thereof |
| 04/16/2009 | WO2008064116A3 Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
| 04/16/2009 | WO2008058358A3 Descriptive report of the patent of invention of the medicament 'rosuvastatin + metformin' in combined form for cardiovascular diseases. |
| 04/16/2009 | WO2008054674A3 Antidiabetic bicyclic compounds |
| 04/16/2009 | WO2008051465A3 Process for making crystalline anhydrous docetaxel |
| 04/16/2009 | WO2008048680A3 Notch 2 signaling as a breast cancer suppressor pathway |
| 04/16/2009 | WO2008047952A3 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound |
| 04/16/2009 | WO2008043840A3 Anti-infective thiourea compounds |
| 04/16/2009 | WO2008040002A9 Methods, compositions and articles of manufacture for hif modulating compounds |
| 04/16/2009 | WO2008035356A3 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 04/16/2009 | WO2008033285A3 Delivery of double-stranded rna into the central nervous system |
| 04/16/2009 | WO2008032072A8 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 04/16/2009 | WO2008029417A3 Pharmaceutical formulation for use in hiv therapy |
| 04/16/2009 | WO2008017867A3 Antiretroviral solid oral composition with at least one water insoluble polymer |
| 04/16/2009 | WO2008015340A3 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapuetic application thereof |
| 04/16/2009 | WO2008011483A3 Methods for treating chronic pain using 1- (hetero) aryl-1-hydroxy 2,3-diamino-propyl amines and related compounds |
| 04/16/2009 | WO2008011453A3 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLβ-HSD-1 |
| 04/16/2009 | WO2008011272A3 Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions |
| 04/16/2009 | WO2008010235A3 An improved process for the preparation of donepezil |
| 04/16/2009 | WO2008010008A3 Cardiovascular combinations using rennin-angiotensin inhibitors |
| 04/16/2009 | WO2007144900A3 Carvedilol phosphate sesquihydrate |